LOMITAPIDE MESYLATE
| Brand name | JUXTAPID |
|---|---|
| Active ingredient | LOMITAPIDE MESYLATE |
| Strength | EQ 60MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | April 2015 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7932268 | August 2027 | use U-1316 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.